NHS pre-diabetes clinics for children are to be set up after a “landmark” study confirmed the feasibility of using ...

A stroke patient at HonorHealth Research Institute is the first in Arizona to receive a new investigational treatment that ...

Gedatolisib's NDA for advanced breast cancer treatment has been accepted by the FDA, with a priority review and a PDUFA date set for July 17, 2026. The drug is intended for HR+/HER2–, PIK3CA wild-type ...

Pope Leo XIV has criticized the administration’s treatment of migrants, its antipathy toward Europe and the use of what he characterized as 'diplomacy based on force.' ...

At the San Antonio Breast Cancer Symposium, researchers discussed how results from HER2CLIMB-05 may inform first-line ...

An initial 6-week course of intranasal saline resolved symptoms for 29.5% of 3- to 12-year-olds with obstructive ...

High probability of technical success in pivotal Phase 3 trial based on unmatched efficacy data for third-line non-small cell ...

Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...

QRX003 has received Orphan Drug and Pediatric Rare Disease Designations from the U.S. Food and Drug Administration and Orphan Drug Designation from the European Medicines Agency for the potential ...

Cohort 4 data demonstrated positive safety and efficacy results, including additional clinical benefit observed following ...

This guidance is for integrated care boards (ICBs) and providers of eating disorder services and sets out how to design collaborative, integrated services that support all children, young people, and ...

The PPP tender was launched on 6 December 2022 by the Ministry of Infrastructure and Transport through a call for expressions ...